Amicus Therapeutics Inc. buy Cantor Fitzgerald
Start price
20.09.24
/
50%
€10.00
Target price
20.09.25
€17.90
Performance (%)
-49.50%
Price
15.07.25
€5.35
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Amicus Therapeutics Inc. is performing very badly with a performance of -49.50%. This prediction currently runs until 20.09.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | 0.980% | 0.980% |
| iShares Core DAX® | -0.727% | 2.783% |
| iShares Nasdaq 100 | 1.839% | 5.294% |
| iShares Nikkei 225® | -2.033% | -0.196% |
| iShares S&P 500 | 1.334% | 4.044% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.00
15.01.25
15.01.25
€20.29
15.01.26
15.01.26
-43.89%
15.07.25
15.07.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.00
07.11.24
07.11.24
€19.47
07.11.25
07.11.25
-49.00%
15.07.25
15.07.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.80
29.02.24
29.02.24
€20.36
28.02.25
28.02.25
-24.15%
01.03.25
01.03.25